Skip to main content
Signal8

Moses Jennifer K.

SEC insider (Form 3/4/5 filer). CIK 0001706667. Director at Viridian Therapeutics, Inc.\DE (VRDN). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in WALTHAM, MA.

Companies Moses Jennifer K. has filed insider reports for

  • Viridian Therapeutics, Inc.\DE (VRDN): Director
Moses Jennifer K. profile photo

Moses Jennifer K.

CIK: 0001706667

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Viridian Therapeutics, Inc.\DE logo
VRDN

Viridian Therapeutics, Inc.\DE

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Viridian Therapeutics, Inc.\DE logo
    VRDN

    Viridian Therapeutics, Inc.\DE

    Jul 1, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    32.3K shares-
  • Viridian Therapeutics, Inc.\DE logo
    VRDN

    Viridian Therapeutics, Inc.\DE

    Jul 1, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    21K shares-

1-2 of 2